跳至主要内容
临床试验/DRKS00000615
DRKS00000615招募中未知

GABAergic Neurotransmission in Panic Disorder:Psychophysical and neurochemical Predictors of Therapy Outcome

Klinik für Psychiatrie und Psychotherapie, UK SH, Campus Lübeck0 个研究点目标入组 20 人开始时间: 2011年1月13日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Age: 18-60 years
  • Right handedness
  • Panic disorder (with or without agoraphobia) according to DSM-IV as primary diagnosis
  • PAS: 19 or greater

排除标准

  • General exclusion criteria for MRI (www.mrsafety.com)
  • Substance dependence or abuse
  • Psychotic disorders
  • Neurological disorders or history of brain trauma
  • Severe chronic somatic disorders
  • 24h before measurement: Alcohol, Nicotine, Sleep deprivation, Drugs and psychoactive substances, particularly tranquilizer, sleep medication (except of SSRI in a stable dose since 6 weeks)
  • Control subjects: History of psychiatric disorders according to SCID screening

研究者

发起方
Klinik für Psychiatrie und Psychotherapie, UK SH, Campus Lübeck

相似试验

GABAergic Neurotransmission in Panic... | 临床试验